相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells
Andrew J. Wilson et al.
CANCER BIOLOGY & THERAPY (2011)
Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells
Shinji Endo et al.
CANCER SCIENCE (2011)
Recent Advances in p53 Research and Cancer Treatment
Kazufumi Suzuki et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
The ubiquitin-proteasome system is inhibited by p53 protein expression in human ovarian cancer cells
In Young Hwang et al.
CANCER LETTERS (2010)
Mdm2-mediated ubiquitylation: p53 and beyond
J-C Marine et al.
CELL DEATH AND DIFFERENTIATION (2010)
Cross talk between stimulated NF-κB and the tumor suppressor p53
G. Schneider et al.
ONCOGENE (2010)
The p53 orchestra: Mdm2 and Mdmx set the tone
Mark Wade et al.
TRENDS IN CELL BIOLOGY (2010)
p53 Attenuates Lipopolysaccharide-Induced NF-κB Activation and Acute Lung Injury
Gang Liu et al.
JOURNAL OF IMMUNOLOGY (2009)
Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53
Tom Van Maerken et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification
Keiko Kawauchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activated p53 induces NF-κB DNA binding but suppresses its transcriptional activation
Keiko Kawauchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
IL-8 and p53 are inversely regulated through JNK, p38 and NF-κB p65 in HepG2 cells during an inflammatory response
M. K. Rasmussen et al.
INFLAMMATION RESEARCH (2008)
Early events in the pathogenesis of epithelial ovarian cancer
Charles N. Landen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth - Implications for therapy
Dineo Khabele et al.
CANCER BIOLOGY & THERAPY (2007)
Phosphorylation of CBP by IKKα promotes cell growth by switching the binding preference of CBP from p53 to NF-κB
Wei-Chien Huang et al.
MOLECULAR CELL (2007)
The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis
Gong Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Incessant ovulation, inflammation and epithelial ovarian carcinogenesis:: Revisiting old hypotheses
JS Fleming et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Lysophosphatidic acid is a major regulator of growth-regulated oncogene α in ovarian cancer.
Z Lee et al.
CANCER RESEARCH (2006)
CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27
S Kagami et al.
EXPERIMENTAL DERMATOLOGY (2006)
Modulation of p53 activity by IκBα:: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors
DH Dreyfus et al.
BMC IMMUNOLOGY (2005)
Identification and characterization of the IKKα promoter -: Positive and negative regulation by ETS-1 and p53, respectively
LB Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p53 induces NF-κB activation by an IκB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1
J Bohuslav et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulated production of the chemokine CCL28 in human colon epithelium
H Ogawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Transfection of a dominant-negative mutant NF-κB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells:: interaction of IkBm and p53
MX Zhou et al.
ONCOGENE (2003)
Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma
E Schutyser et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
MDM2 induces NF-κB/p65 expression transcriptionally through Sp1-binding sites:: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia
LB Gu et al.
BLOOD (2002)
Control of IκBα proteolysis by the ubiquitin-proteasome pathway
K Tanaka et al.
BIOCHIMIE (2001)
p300/CBP-dependent and -independent transcriptional interference between NF-κB RelA and p53
A Ikeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Development of a syngeneic mouse model for events related to ovarian cancer
KF Roby et al.
CARCINOGENESIS (2000)
分享论文
